C07D 491/12
In which the condensed system contains three hetero rings
Official title: in which the condensed system contains three hetero rings
C07D491/12 (In which the condensed system contains three hetero rings) appears on 1,394 US grants and 1,734 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,394
- Published applications
- 1,734
- Assignees
- 851
- Inventors
- 5,658
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 7 | 0 |
| 1978 | 8 | 0 |
| 1979 | 8 | 0 |
| 1980 | 5 | 0 |
| 1981 | 9 | 0 |
| 1982 | 4 | 0 |
| 1983 | 7 | 0 |
| 1984 | 8 | 0 |
| 1985 | 7 | 0 |
| 1986 | 7 | 0 |
| 1987 | 10 | 0 |
| 1988 | 8 | 0 |
| 1989 | 7 | 0 |
| 1990 | 6 | 0 |
| 1991 | 7 | 0 |
| 1992 | 15 | 0 |
| 1993 | 14 | 0 |
| 1994 | 10 | 0 |
| 1995 | 13 | 0 |
| 1996 | 25 | 0 |
| 1997 | 17 | 0 |
| 1998 | 11 | 0 |
| 1999 | 10 | 0 |
| 2000 | 17 | 0 |
| 2001 | 18 | 2 |
| 2002 | 21 | 19 |
| 2003 | 21 | 26 |
| 2004 | 13 | 42 |
| 2005 | 18 | 41 |
| 2006 | 25 | 41 |
| 2007 | 25 | 38 |
| 2008 | 24 | 47 |
| 2009 | 25 | 56 |
| 2010 | 31 | 62 |
| 2011 | 34 | 70 |
| 2012 | 37 | 66 |
| 2013 | 53 | 59 |
| 2014 | 52 | 83 |
| 2015 | 61 | 75 |
| 2016 | 65 | 92 |
| 2017 | 80 | 95 |
| 2018 | 74 | 81 |
| 2019 | 72 | 76 |
| 2020 | 69 | 106 |
| 2021 | 62 | 78 |
| 2022 | 57 | 93 |
| 2023 | 52 | 116 |
| 2024 | 58 | 94 |
| 2025 | 61 | 99 |
| 2026 | 39 | 77 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compounds, compositions, and methods29 Sep 2026US 12,747,232 B2Denali Therapeutics Inc.
- Substituted [1,2,4]triazolo[4,3-a]quinoxalines, dosage forms containing them, and methods of using them to treat or prevent pain and/or inflammation29 Sep 2026US 12,747,240 B2Gruenenthal GmbH
- EIF4A-inhibiting compounds and methods related thereto29 Sep 2026US 12,747,249 B2SJP Biotec GmbH
- Solid supports and phosphoramidite building blocks for oligonucleotide conjugates15 Sep 2026US 12,735,387 B2AM Chemicals LLC
- Plasmin inhibitor, preparation method therefor, and application thereof15 Sep 2026US 12,735,421 B2Scinnohub Pharmaceutical Co., Ltd
- Benzo-fused ring compound inhibitor, and preparation method therefor and use thereof1 Oct 2026US 2026/0297071 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Organic electroluminescent element and electronic device1 Oct 2026US 2026/0297107 A1Idemitsu Kosan Co., Ltd.
- Inhibitors of parg24 Sep 2026US 2026/0285875 A1858 Therapeutics, Inc.
- 3h-pyrazolo[4.3:f] quinoline-based compounds as sting antagonists17 Sep 2026US 2026/0274838 A1Purdue Research Foundation
- Crystal of dihydropyridinone derivative or solvate thereof17 Sep 2026US 2026/0274857 A1Shionogi & Co., Ltd.
Most cited
By later US patents
- Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family225US 5,654,307 AWarner-Lambert Company · 1997
- Sulfonated xanthene derivatives204US 6,130,101 AMolecular Probes, Inc. · 2000
- Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes164US 5,227,487 AMolecular Probes, Inc. · 1993
- Dimeric and trimeric nucleic acid dyes, and associated systems and methods164US 7,776,567 B2AlleLogic Biosciences Corporation · 2010
- Biological conjugates of fluorescent rhodol dyes133US 5,442,045 AMolecular Probes, Inc. · 1995